VIVUS, Inc. (VVUS) Reports Second Quarter and First Six Months 2013 Financial Results
8/7/2013 9:28:48 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
MOUNTAIN VIEW, Calif., Aug. 6, 2013 (GLOBE NEWSWIRE) -- VIVUS,Inc. (Nasdaq:VVUS) ("VIVUS"), which sells the obesity drug Qsymia® (phentermine and topiramate extended-release) capsules CIV in the United States, today provided a business update and reported its financial results for the second quarter and six months ended June 30, 2013.
Help employers find you! Check out all the jobs and post your resume.
comments powered by